Zimmer Biomet Holdings Inc [ZBH] stock is trading at $104.75, up 0.73%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ZBH shares have lost -0.16% over the last week, with a monthly amount drifted -3.15%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Zimmer Biomet Holdings Inc [NYSE: ZBH] stock has seen the most recent analyst activity on December 17, 2024, when JP Morgan upgraded its rating to a Overweight and also boosted its price target to $128 from $125. On July 01, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $115 on the stock. Goldman started tracking the stock assigning a Neutral rating and suggested a price target of $129 on May 30, 2024. Argus upgraded its rating to a Buy but $150 remained the price target by the analyst firm on May 21, 2024. Evercore ISI downgraded its rating to In-line for this stock on January 04, 2024, and downed its price target to $125. In a note dated October 20, 2023, ROTH MKM initiated an Neutral rating and provided a target price of $120 on this stock.
Zimmer Biomet Holdings Inc [ZBH] stock has fluctuated between $97.69 and $133.90 over the past year. Currently, Wall Street analysts expect the stock to reach $120.6 within the next 12 months. Zimmer Biomet Holdings Inc [NYSE: ZBH] shares were valued at $104.75 at the most recent close of the market. An investor can expect a potential return of 15.13% based on the average ZBH price forecast.
Analyzing the ZBH fundamentals
Zimmer Biomet Holdings Inc [NYSE:ZBH] reported sales of 7.68B for the trailing twelve months, which represents a growth of 4.28%. Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.12%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.07 and Total Capital is 0.07. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.43.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 103.40 points at the first support level, and at 102.05 for the second support level. However, for the 1st resistance point, the stock is sitting at 105.91, and for the 2nd resistance point, it is at 107.07.
Ratios To Look Out For
For context, Zimmer Biomet Holdings Inc’s Current Ratio is 1.91. Further, the Quick Ratio stands at 0.99, while the Cash Ratio is 0.33. Considering the valuation of this stock, the price to sales ratio is 2.72, the price to book ratio is 1.67 and price to earnings (TTM) ratio is 23.61.
Transactions by insiders
Recent insider trading involved Winkler Lori, Officer, that happened on Mar 05 ’25 when 1443.0 shares were purchased. Group President, Asia Pacific, Yi Sang completed a deal on May 31 ’24 to sell 12857.0 shares. Meanwhile, Group President, Asia Pacific Yi Sang sold 1705.0 shares on Mar 07 ’24.
